Financial Performance - Net profit attributable to shareholders decreased by 24.51% to CNY 13,875,693.85 year-on-year[10] - Operating revenue declined by 5.91% to CNY 66,663,253.61 compared to the same period last year[10] - The net cash flow from operating activities turned negative at CNY -6,383,753.48, a decrease of 135.73% year-on-year[10] - Total operating revenue for Q1 2023 was ¥66,663,253.61, a decrease from ¥70,853,210.95 in Q1 2022[33] - Net profit for Q1 2023 was ¥12,931,524.95, down from ¥17,905,085.94 in Q1 2022, representing a decline of approximately 28.5%[34] - Basic and diluted earnings per share for Q1 2023 were both ¥0.42, compared to ¥0.61 in Q1 2022[35] - Operating revenue for Q1 2023 was approximately ¥49.63 million, a decrease of 20.9% compared to ¥62.75 million in Q1 2022[37] - Net profit for Q1 2023 reached ¥14.76 million, representing an increase of 4.7% from ¥14.10 million in Q1 2022[37] - The total comprehensive income for Q1 2023 was ¥14.76 million, compared to ¥14.10 million in Q1 2022[38] Assets and Liabilities - Total assets increased by 31.39% to CNY 500,231,235.48 compared to the end of last year[10] - The company's total liabilities to assets ratio decreased to 10.46% from 14.67% at the end of the previous year[10] - Total current assets increased to ¥331,426,442.96 as of March 31, 2023, up from ¥211,003,184.81 at December 31, 2022, representing a growth of 57.1%[27] - Total assets reached ¥500,231,235.48, up from ¥380,716,880.35, indicating an increase of 31.5%[28] - Total liabilities decreased to ¥52,303,707.00 from ¥55,857,207.55, a reduction of 6.5%[29] - Shareholders' equity increased significantly to ¥447,927,528.48 from ¥324,859,672.80, representing a growth of 38.0%[29] - Total liabilities increased to ¥34,124,938.73 from ¥33,758,192.20[32] - Shareholders' equity rose to ¥429,125,817.74 from ¥304,232,437.50[32] Cash Flow - The company’s fundraising activities resulted in an increase in cash flow from financing activities compared to the previous year[14] - Cash flow from operating activities showed a net outflow of ¥6.38 million in Q1 2023, compared to a net inflow of ¥17.87 million in Q1 2022[41] - Cash and cash equivalents at the end of Q1 2023 totaled ¥127.01 million, significantly up from ¥21.10 million at the end of Q1 2022[41] - The net increase in cash and cash equivalents was $67.86 million, contrasting with a decrease of -$19.42 million last year[43] - Cash received from sales of goods and services was $30.45 million, compared to $64.90 million previously[43] - Cash paid for purchasing goods and services was $27.39 million, down from $39.74 million[43] - Cash received from other operating activities was $7.54 million, significantly higher than $82,081.10 last year[43] Shareholder Information - The number of ordinary shareholders increased to 2,638 by the end of the reporting period[16] - The company has fulfilled all disclosed commitments without any significant changes during the reporting period[23] Government Support and Subsidies - The company received government subsidies amounting to CNY 1,703,920.95 during the reporting period[13] Research and Development - Research and development expenses for Q1 2023 were ¥3,555,986.54, compared to ¥2,873,311.18 in Q1 2022, indicating a growth of approximately 23.7%[33] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[30] Operational Stability - The company has no ongoing litigation or arbitration matters, ensuring a stable operational environment[22] - There were no major acquisitions or asset sales reported during the quarter, indicating a focus on internal growth[22] - The company has maintained a strong financial position with no external guarantees or loans provided[22] - The company has a robust internal audit process in place, ensuring compliance with financial reporting standards[26] Inventory and Other Assets - The company reported a notable increase in inventory, which rose to ¥68,643,278.96 from ¥67,368,365.91, an increase of 1.9%[27] - The company has maintained a strong capital reserve, which increased to ¥134,202,020.33 from ¥34,185,689.60, a growth of 292.5%[29] - Total non-current assets decreased slightly to ¥168,804,792.52 from ¥169,713,695.54, a decline of 0.5%[28] - Total assets pledged amounted to 13,368,031.17, representing 2.67% of total assets, primarily due to bank acceptance bills and guarantees[24] User Data and Market Expansion - The company reported a significant increase in user data, with a growth rate of 62.46% compared to the previous period[19] - The company is actively monitoring market expansion opportunities but has not disclosed specific new products or technologies in development[22]
峆一药业(430478) - 2023 Q1 - 季度财报